These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28408497)

  • 1. Iminosugar antivirals: the therapeutic sweet spot.
    Alonzi DS; Scott KA; Dwek RA; Zitzmann N
    Biochem Soc Trans; 2017 Apr; 45(2):571-582. PubMed ID: 28408497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.
    Sayce AC; Alonzi DS; Killingbeck SS; Tyrrell BE; Hill ML; Caputo AT; Iwaki R; Kinami K; Ide D; Kiappes JL; Beatty PR; Kato A; Harris E; Dwek RA; Miller JL; Zitzmann N
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004524. PubMed ID: 26974655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2.
    Zhao X; Guo F; Comunale MA; Mehta A; Sehgal M; Jain P; Cuconati A; Lin H; Block TM; Chang J; Guo JT
    Antimicrob Agents Chemother; 2015 Jan; 59(1):206-16. PubMed ID: 25348530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iminosugars: A host-targeted approach to combat Flaviviridae infections.
    Evans DeWald L; Starr C; Butters T; Treston A; Warfield KL
    Antiviral Res; 2020 Dec; 184():104881. PubMed ID: 32768411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue).
    Warfield KL; Plummer E; Alonzi DS; Wolfe GW; Sampath A; Nguyen T; Butters TD; Enterlein SG; Stavale EJ; Shresta S; Ramstedt U
    Viruses; 2015 May; 7(5):2404-27. PubMed ID: 25984714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity.
    Karade SS; Hill ML; Kiappes JL; Manne R; Aakula B; Zitzmann N; Warfield KL; Treston AM; Mariuzza RA
    J Med Chem; 2021 Dec; 64(24):18010-18024. PubMed ID: 34870992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus.
    Miller JL; Tyrrell BE; Zitzmann N
    Adv Exp Med Biol; 2018; 1062():277-301. PubMed ID: 29845540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo.
    Warfield KL; Warren TK; Qiu X; Wells J; Mire CE; Geisbert JB; Stuthman KS; Garza NL; Van Tongeren SA; Shurtleff AC; Agans KN; Wong G; Callahan MV; Geisbert TW; Klose B; Ramstedt U; Treston AM
    Antiviral Res; 2017 Feb; 138():22-31. PubMed ID: 27908828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic applications of iminosugars: current perspectives and future opportunities.
    Horne G; Wilson FX
    Prog Med Chem; 2011; 50():135-76. PubMed ID: 21315930
    [No Abstract]   [Full Text] [Related]  

  • 10. Iminosugars as possible broad spectrum anti hepatitis virus agents: the glucovirs and alkovirs.
    Block TM; Jordan R
    Antivir Chem Chemother; 2001 Nov; 12(6):317-25. PubMed ID: 12018676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iminosugars counteract the downregulation of the interferon γ receptor by dengue virus.
    Miller JL; Hill ML; Brun J; Pountain A; Sayce AC; Zitzmann N
    Antiviral Res; 2019 Oct; 170():104551. PubMed ID: 31306674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses.
    Chang J; Warren TK; Zhao X; Gill T; Guo F; Wang L; Comunale MA; Du Y; Alonzi DS; Yu W; Ye H; Liu F; Guo JT; Mehta A; Cuconati A; Butters TD; Bavari S; Xu X; Block TM
    Antiviral Res; 2013 Jun; 98(3):432-40. PubMed ID: 23578725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iminosugars as therapeutic agents: recent advances and promising trends.
    Nash RJ; Kato A; Yu CY; Fleet GW
    Future Med Chem; 2011 Sep; 3(12):1513-21. PubMed ID: 21882944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structures of mammalian ER α-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals.
    Caputo AT; Alonzi DS; Marti L; Reca IB; Kiappes JL; Struwe WB; Cross A; Basu S; Lowe ED; Darlot B; Santino A; Roversi P; Zitzmann N
    Proc Natl Acad Sci U S A; 2016 Aug; 113(32):E4630-8. PubMed ID: 27462106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue Virus Evolution under a Host-Targeted Antiviral.
    Plummer E; Buck MD; Sanchez M; Greenbaum JA; Turner J; Grewal R; Klose B; Sampath A; Warfield KL; Peters B; Ramstedt U; Shresta S
    J Virol; 2015 May; 89(10):5592-601. PubMed ID: 25762732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers.
    Branza-Nichita N; Durantel D; Carrouée-Durantel S; Dwek RA; Zitzmann N
    J Virol; 2001 Apr; 75(8):3527-36. PubMed ID: 11264342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel imino sugar α-glucosidase inhibitors as antiviral compounds.
    Howe JD; Smith N; Lee MJ; Ardes-Guisot N; Vauzeilles B; Désiré J; Baron A; Blériot Y; Sollogoub M; Alonzi DS; Butters TD
    Bioorg Med Chem; 2013 Aug; 21(16):4831-8. PubMed ID: 23582447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Design of Potent Iminosugar Inhibitors of Endoplasmic Reticulum α-Glucosidase I with Anti-SARS-CoV-2 Activity.
    Karade SS; Franco EJ; Rojas AC; Hanrahan KC; Kolesnikov A; Yu W; MacKerell AD; Hill DC; Weber DJ; Brown AN; Treston AM; Mariuzza RA
    J Med Chem; 2023 Feb; 66(4):2744-2760. PubMed ID: 36762932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.
    Chang J; Block TM; Guo JT
    Antiviral Res; 2013 Sep; 99(3):251-60. PubMed ID: 23816430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-glucosidase inhibitors as potential broad based anti-viral agents.
    Mehta A; Zitzmann N; Rudd PM; Block TM; Dwek RA
    FEBS Lett; 1998 Jun; 430(1-2):17-22. PubMed ID: 9678587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.